Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Generex Biotechnology Corporation (OP: GNBT)
0.0273 USD  +0.0003 (+1.11%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Generex Biotechnology Corporation
 
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stocks on watch for next week
December 17, 2011
category ELN , GNBT , ZLCS , and 2 more.
from AC Investor Blog
Stocks On Watch For Next Week
December 17, 2011
( click to enlarge ) Novatel Wireless, Inc. (NASDAQ:NVTL) was one of the winners on Friday. The stock closed just below the high of the day which tells us there were buyers in the stock all day. This... Read More
category ELN , GNBT , ZLCS , and 6 more.
from DailyMarkets.com
Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television
December 14, 2011
Vaccine Also Referenced in Newsweek Magazine Read More
from PR Newswire
Generex Biotech and Avanir Pharmaceuticals Look to Rally in 2012
December 12, 2011
The Paragon Report Provides Equity Research on Generex Biotechnology & Avanir Pharmaceuticals Read More
from Marketwired News Releases
Generex Biotechnology Corp. (OTC:GNBT) Climbs Up on Hot News
December 09, 2011
Generex Biotechnology Corp. (OTC:GNBT) has been moving up since Tuesday. Yesterday, the stock price jumped up 16.67% and its traded volume exceeded 7 million shares. Apparently, the massive trade was... Read More
category Stocks
from Hotstocked.com articles
Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at SABCS
December 08, 2011
Positive Top-line Interim Results from Phase 2 Study of AE37 presented this week: Final Phase 2 Results Expected in 2012 Read More
from PR Newswire
Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
December 07, 2011
Clinical Data Provides Further Evidence of Effectiveness in Treatment of Prediabetes Read More
from PR Newswire
Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
December 01, 2011
Company Reschedules Conference Call to Early January Read More
from PR Newswire
Generex Subsidiary Antigen Express to Present AE37 Cancer Vaccine Phase 2 Clinical Data at 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
November 21, 2011
Antigen Express Also Awarded Core Ii-Key Hybrid Platform Technology Patent in Japan Read More
from PR Newswire
Generex Announces Investor Update Conference Call Planned for Late November
October 24, 2011
from PR Newswire
Antigen Express to Present at Second Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference at the New York Academy of Medicine
October 06, 2011
from PR Newswire
Biotech Stocks Reporting on Breast Cancer Treatments; (OTC: AEMD), (NASDAQ: SPPI), (NASDAQ:RXII), (OTCBB: GNBT)
September 23, 2011
Northern, WI 9/23/2011  ( PennyPayDay )   September 23, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, issues an update and... Read More
from Street Beat: Articles
Biotech Stocks Reporting on Breast Cancer Treatments; (OTC: AEMD), (NASDAQ: SPPI), (NASDAQ:RXII), (OTCBB: GNBT)
September 23, 2011
Northern, WI 9/23/2011  ( PennyPayDay )   September 23, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, issues an update and... Read More
from Street Beat: Articles
Biotech Stocks Reporting on Breast Cancer Treatments; (OTC: AEMD), (NASDAQ: SPPI), (NASDAQ:RXII), (OTCBB: GNBT)
September 23, 2011
Point Roberts, WA - September 23, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, issues an update and recent news from... Read More
from Investorideas.com newswire, stock news and business news for investors
Antigen Express' AE37 Cancer Vaccine Featured in Scientific American
September 21, 2011
Article coincides with Breast Cancer Awareness Month in October Read More
from PR Newswire
Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy
September 19, 2011
AE37, a novel HER-2/neu-targeted vaccine, is being evaluated for the treatment of breast, prostate, and other cancers Read More
from PR Newswire
Generex Makes Podium Presentation of Clinical Data on Generex Oral-lyn™ at European Association for the Study of Diabetes Annual Meeting
September 16, 2011
Clinical Data Provides Further Evidence of Pre-diabetes Use Read More
from PR Newswire
Generex Provides Update on Spinout of Antigen Express
September 15, 2011
from PR Newswire
Generex to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
September 07, 2011
from PR Newswire
Generex Augments Cash Position With Sales of Non-Essential Assets
September 06, 2011
from PR Newswire
Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
August 18, 2011
from PR Newswire
Generex Biotechnology Corp. (OTC:GNBT) Stock Fell Down Again
August 11, 2011
Yesterday, Generex Biotechnology Corp. (OTC:GNBT) broke up the climb and took the way down again. The stock lost 2.54% for the day and its traded volume substantially decreased. However, the strangest... Read More
category Stocks
from Hotstocked.com articles
Generex Biotechnology Corp. (OTC:GNBT) Bounces Up from the Bottom
August 10, 2011
At the beginning of the week, the long-lasting downtrend of Generex Biotechnology Corp. ( OTC:GNBT ) stock resulted in a new bottom for the share price. Although GNBT recovered the losses yesterday, it... Read More
category Stocks
from Hotstocked.com articles
Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
August 04, 2011
Partnership Aimed at Groundbreaking Beta-Cell Replacement Read More
from PR Newswire
Generex Provides Corporate Update
August 02, 2011
from PR Newswire
Mentor Capital Cancer Immunotherapy Index Outpaces Biotechs on Second Anniversary
July 12, 2011
from Business Wire News Releases
Amarantus BioSciences and Generex Biotechnology Announce Collaboration to Treat Pre-Diabetes
July 12, 2011
from Marketwired News Releases
OTCSHUB.com Continues Its Coverage of Portage Resources
July 11, 2011
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO NewsWire. Read More
from Marketwired News Releases
Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology
July 11, 2011
from PR Newswire
Generex Announces $2.575 Million Capital Investment
July 11, 2011
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here